08/30/2026
Professor Michal Hershfinkel of BGU International is exploring a new approach to stopping cancer cells from spreading.
Her ICRF-funded research focuses on ZnR/GPR39, a zinc-sensing receptor that her lab has found can drive cancer cell growth, movement, and invasion.
Using advanced gene-silencing approaches and targeted lipid nanoparticles, the research will be tested in models of breast cancer and glioblastoma.
This work could open the door to a new therapeutic strategy for aggressive, therapy-resistant cancers where more treatment options are urgently needed.
The answer to cancer is research. 💙